Your browser doesn't support javascript.
loading
LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.
Wei, Wei-Qi; Li, Xiaohui; Feng, Qiping; Kubo, Michiaki; Kullo, Iftikhar J; Peissig, Peggy L; Karlson, Elizabeth W; Jarvik, Gail P; Lee, Ming Ta Michael; Shang, Ning; Larson, Eric A; Edwards, Todd; Shaffer, Christian M; Mosley, Jonathan D; Maeda, Shiro; Horikoshi, Momoko; Ritchie, Marylyn; Williams, Marc S; Larson, Eric B; Crosslin, David R; Bland, Harris T; Pacheco, Jennifer A; Rasmussen-Torvik, Laura J; Cronkite, David; Hripcsak, George; Cox, Nancy J; Wilke, Russell A; Stein, C Michael; Rotter, Jerome I; Momozawa, Yukihide; Roden, Dan M; Krauss, Ronald M; Denny, Joshua C.
Afiliação
  • Wei WQ; Department of Biomedical Informatics (W.-Q.W., J.D.M., J.C.D.), Vanderbilt University Medical Center, Nashville, TN.
  • Li X; The Institute for Translational Genomics and Population Sciences, Departments of Pediatrics and Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA (X.L., J.I.R.).
  • Feng Q; Division of Clinical Pharmacology (Q.F., C.S., J.D.M., C.M.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
  • Kubo M; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan (M.K., S.M., M.H., Y.M.).
  • Kullo IJ; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (I.J.K.).
  • Peissig PL; Center for Precision Medicine Research, Marshfield Clinic Research Institute, WI (P.L.P.).
  • Karlson EW; Division of Rheumatology, Immunology and Allergy, Brigham & Women's Hospital and Harvard Medical School, Boston, MA (E.W.K.).
  • Jarvik GP; Departments of Medicine (Medical Genetics) and Genome Sciences (G.P.J., D.C.), University of Washington, Seattle.
  • Lee MTM; Genomic Medicine Institute, Geisinger, Danville, PA (M.T.M.L., M.S.W.).
  • Shang N; Department of Biomedical Informatics, Columbia University, New York, NY (N.S., G.H.).
  • Larson EA; Sanford School of Medicine, University of South Dakota, Sioux Falls (E.A.L., R.A.W.).
  • Edwards T; Vanderbilt Genetics Institute and the Division of Genetic Medicine, Vanderbilt University, Nashville, TN (T.E., N.J.C.).
  • Shaffer CM; Division of Clinical Pharmacology (Q.F., C.S., J.D.M., C.M.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
  • Mosley JD; Department of Biomedical Informatics (W.-Q.W., J.D.M., J.C.D.), Vanderbilt University Medical Center, Nashville, TN.
  • Maeda S; Division of Clinical Pharmacology (Q.F., C.S., J.D.M., C.M.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
  • Horikoshi M; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan (M.K., S.M., M.H., Y.M.).
  • Ritchie M; Department of Advanced Genomic and Laboratory Medicine, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan (S.M.).
  • Williams MS; Division of Clinical Laboratory and Blood Transfusion, University of the Ryukyus Hospital, Nishihara, Japan (S.M.).
  • Larson EB; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan (M.K., S.M., M.H., Y.M.).
  • Crosslin DR; Center for Translational Bioinformatics, Institute for Biomedical Informatics, Institute for Biomedical Informatics, Center for Precision Medicine, University of Pennsylvania, Philadelphia (M.R.).
  • Bland HT; Genomic Medicine Institute, Geisinger, Danville, PA (M.T.M.L., M.S.W.).
  • Pacheco JA; Kaiser Permanente Washington Health Research Institute, Seattle (E.B.L., D.C.).
  • Rasmussen-Torvik LJ; Department of Biomedical Informatics and Medical Education (D.R.C.), University of Washington, Seattle.
  • Cronkite D; Vanderbilt Institute for Clinical and Translational Research (S.T.B.), Vanderbilt University Medical Center, Nashville, TN.
  • Hripcsak G; Feinberg School of Medicine, Northwestern University, Chicago, IL (J.A.P., L.J.R.-T.).
  • Cox NJ; Feinberg School of Medicine, Northwestern University, Chicago, IL (J.A.P., L.J.R.-T.).
  • Wilke RA; Departments of Medicine (Medical Genetics) and Genome Sciences (G.P.J., D.C.), University of Washington, Seattle.
  • Stein CM; Kaiser Permanente Washington Health Research Institute, Seattle (E.B.L., D.C.).
  • Rotter JI; Department of Biomedical Informatics, Columbia University, New York, NY (N.S., G.H.).
  • Momozawa Y; Vanderbilt Genetics Institute and the Division of Genetic Medicine, Vanderbilt University, Nashville, TN (T.E., N.J.C.).
  • Roden DM; Sanford School of Medicine, University of South Dakota, Sioux Falls (E.A.L., R.A.W.).
  • Krauss RM; Division of Clinical Pharmacology (Q.F., C.S., J.D.M., C.M.S., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
  • Denny JC; Department of Medicine (C.M.S., D.M.R., J.C.D.), Vanderbilt University Medical Center, Nashville, TN.
Circulation ; 138(17): 1839-1849, 2018 10 23.
Article em En | MEDLINE | ID: mdl-29703846
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Lipoproteína(a) / Inibidores de Hidroximetilglutaril-CoA Redutases / Doença das Coronárias / Polimorfismo de Nucleotídeo Único / Dislipidemias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Tunísia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Lipoproteína(a) / Inibidores de Hidroximetilglutaril-CoA Redutases / Doença das Coronárias / Polimorfismo de Nucleotídeo Único / Dislipidemias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Tunísia